PARIS, October 29, 2015 /PRNewswire/ --

Sanofi, a global and diversified healthcare leader, reports results for the third quarter of 2015. Jérôme Contamine, Chief Financial Officer of Sanofi, comments on the Group's Q3 results.

Watch video interview and read transcript:

http://www.eurobusinessmedia.com/ceo-direct/sanofi/q3-2015-results-interview-with-cfo-jerome-contamine?utm_source=ceo-direct&utm_medium=wire

Topics covered in the interview include:

• Q3 results
• Diabetes
• Guidance
• Genzyme
• Vaccines
• Merial
• Praluent®
• Emerging Markets

About Sanofi

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

SOURCE Sanofi